Abion Venture Capital
4 known investors
Abion is a clinical-stage biopharmaceutical company developing novel oncology and antiviral therapeutics, including targeted cancer treatments and prophylactic therapies for respiratory viruses. The company focuses on best-in-class and first-in-class drug candidates for global clinical development and commercialization.